NEW YORK – Indivumed said on Wednesday that it has launched an international collaborative called the Oncology Alliance for Individualized Medicine to advance precision cancer treatments through the company's multi-omics database IndivuType.
The alliance includes leading cancer clinics and research institutions with molecular oncology expertise across Brazil, Germany, Italy, Ireland, Japan, Korea, Singapore, Spain, Sweden, UK, and US. The specific members of the alliance were not named in a statement announcing its launch.